RETINAL DEGENERATION

This study tests a new treatment called OpCT-001 for people with vision loss due to diseases like retinitis pigmentosa. The treatment involves injecting special cells into the eye to replace damaged light-sensing cells. The study has two parts: first to check safety in a small gr…

This study tests whether dapagliflozin, a drug used for diabetes, can slow the progression of geographic atrophy—an advanced form of dry age-related macular degeneration that causes blind spots. About 70 adults aged 50 and older with this condition will take the drug for 12 month…

This study aims to understand how retinal diseases affect rod and cone cells in the eye by testing how well people see in the dark. Researchers will compare healthy volunteers and people with retinal conditions like retinitis pigmentosa and Stargardt's disease. Participants will …

This study uses special high-resolution and high-speed cameras to take detailed pictures of the eye. Researchers want to see tiny structures, like cells and blood flow, that regular eye exams miss. About 1,200 adults with various eye conditions or healthy volunteers will be image…

This study uses a special camera called adaptive optics to take detailed pictures of the back of the eye in people with outer retinal diseases like age-related macular degeneration and retinitis pigmentosa. Researchers want to develop better ways to diagnose and track these condi…

This study collects skin, hair, blood, urine, or saliva samples from people with certain eye diseases (like macular degeneration) and from healthy volunteers. Researchers will turn these samples into stem cells in the lab to study how the diseases develop and to test potential ne…